Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yuan Lu, Xin Huang, Xiaoke Liu, Yu He, Zhe Hu, Weize Xu, Gang Cao & Wenbo He. (2021) Remodels the Immunosuppressive Tumor Microenvironment by Combination of Bacillus Calmette–Guérin and Anti-PD-L1 in an Orthotopic Triple-Negative Breast Cancer Mouse Model. OncoTargets and Therapy 14, pages 2247-2258.
Read now
Read now
Sandra Guallar-Garrido & Esther Julián. (2020) Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update. ImmunoTargets and Therapy 9, pages 1-11.
Read now
Read now
Articles from other publishers (14)
Shuhang Luo, Yukun Wu, Rui Yang, Gaowei Huang, Jiahao Lei, Jinwen Liu, Shengjie Lin, Lingwu Chen, Junxing Chen & Bin Huang. (2023) Intra-arterial chemotherapy plus BCG, a promising combination adjuvant treatment for high-risk NMIBC. Urologic Oncology: Seminars and Original Investigations.
Crossref
Crossref
Manal M Sami, Mahmoud H Sherief, Taghrid B El-Abaseri, Ahmed I El-Sakka & Ahmed T El-Serafi. (2023) Expression of epidermal growth factor receptor and human epidermal growth factor receptor 2 in urothelial bladder carcinoma in an Egyptian cohort: Clinical implication and prognostic significance. Urologia Journal 90:2, pages 248-260.
Crossref
Crossref
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer
7
159
.
Xinzi Hu, Guangzhi Li & Song Wu. (2022) Advances in Diagnosis and Therapy for Bladder Cancer. Cancers 14:13, pages 3181.
Crossref
Crossref
Anirban P. Mitra, Vikram M. Narayan, Sharada Mokkapati, Tanner Miest, Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella, Ashish M. Kamat, Trinity J. Bivalacqua, Jeffrey S. Montgomery, Seth P. Lerner, J. Erik Busby, Michael Poch, Paul L. Crispen, Gary D. Steinberg, Anne K. Schuckman, Tracy M. Downs, Robert S. Svatek, Joseph Mashni, Brian R. Lane, Thomas J. Guzzo, Gennady Bratslavsky, Lawrence I. Karsh, Michael E. Woods, Gordon A. Brown, Daniel Canter, Adam Luchey, Yair Lotan, Tracey Krupski, Brant A. Inman, Michael B. Williams, Michael S. Cookson, Kirk A. Keegan, Gerald L. Andriole, Alexander I. Sankin, Alan Boyd, Michael A. O'Donnell, Richard Philipson, Seppo Ylä-Herttuala, David Sawutz, Nigel R. Parker, David J. McConkey & Colin P.N. Dinney. (2022) Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. European Urology 81:3, pages 223-228.
Crossref
Crossref
Hajar El Ahanidi, Meryem El Azzouzi, Chaimae Hafidi Alaoui, Mohammed Tetou, Mounia Bensaid, Imane Chaoui, Laila Benbacer, Ilias Hassan, Mohamed Oukabli, Katarzyna Michaud, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed El Mzibri, Camilla Jandus & Mohammed Attaleb. (2022) Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Letícia B. Silva, Kelly A. D. F. Castro, Caroline E. A. Botteon, Cristiano L. P. Oliveira, Roberto S. da Silva & Priscyla D. Marcato. (2021) Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Hannah Slovacek, Jerry Zhuo & Jennifer M. Taylor. (2021) Approaches to Non-Muscle-Invasive Bladder Cancer. Current Oncology Reports 23:9.
Crossref
Crossref
Lu Tang, Jing Li, Qingqing Zhao, Ting Pan, Hui Zhong & Wei Wang. (2021) Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery. Pharmaceutics 13:8, pages 1151.
Crossref
Crossref
Erkko Ylösmäki, Manlio Fusciello, Beatriz Martins, Sara Feola, Firas Hamdan, Jacopo Chiaro, Leena Ylösmäki, Matthew J Vaughan, Tapani Viitala, Prasad S Kulkarni & Vincenzo Cerullo. (2021) Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin. Journal for ImmunoTherapy of Cancer 9:7, pages e002707.
Crossref
Crossref
Khalil El Gharib, Eddy Lilly & Roy Chebel. (2021) Checkpoint inhibitors in BCG-unresponsive nonmuscle invasive bladder cancer: can they help spare the bladder?. Immunotherapy.
Crossref
Crossref
Chiara Nicolazzo, Ettore de Berardinis & Paola Gazzaniga. (2021) Liquid Biopsy for Predicting Bacillus Calmette-Guérin Unresponsiveness in Non–muscle-invasive Bladder Cancer. European Urology Oncology 4:1, pages 124-125.
Crossref
Crossref
Geertje Horst, Arjanneke F. Merbel, Eline Ruigrok, Maaike H. Mark, Emily Ploeg, Laura Appelman, Siri Tvingsholm, Marja Jäätelä, Janneke Uhm, Marianna Kruithof‐de Julio, George N. Thalmann, Rob C. M. Pelger, Chris H. Bangma, Joost L. Boormans, Gabri Pluijm & Ellen C. Zwarthoff. (2020) Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer. Molecular Oncology 14:12, pages 3121-3134.
Crossref
Crossref
Katia Pane, Peppino Mirabelli, Luigi Coppola, Ester Illiano, Marco Salvatore & Monica Franzese. (2020) New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis. Frontiers in Chemistry 8.
Crossref
Crossref